LMD 10% IN DEXTROSE 5% 10 %
DEXTRAN : 10 % DEXTROSE : 5 % · DIN 00224235 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is LMD 10% IN DEXTROSE 5%?
LMD 10% IN DEXTROSE 5% 10 % contains DEXTRAN : 10 % DEXTROSE : 5 %. It is listed in the Health Canada Drug Product Database under DIN 00224235, held by PFIZER CANADA ULC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 20-Sep-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LMD 10% IN DEXTROSE 5% used for?
LMD 10% in Dextrose 5% and LMD 10% in 0.9% Sodium Chloride are indicated in the treatment of shock (hemorrhagic, cardiogenic, septic), for expansion of plasma volume and enhancement of blood flow. They are also indicated as priming fluids in pump-oxygenators for perfusion during extracorporeal circulation, and in impairment of the arterial and venous circulation as in thrombosis, thrombophlebitis, imminent gangrene, ulcus cruris and Raynaud’s disease.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00224235 |
|---|---|
| Brand name | LMD 10% IN DEXTROSE 5% |
| Generic / active ingredient | DEXTRAN : 10 % DEXTROSE : 5 % |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 10 % |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05AA55 DEXTRAN,COMBINATIONS |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Sep-2017 |
| Original market date | 1968-12-31 00:00:00 |
How is it stored and handled?
Storage should be at a constant temperature, preferably between 20 and 25°C
How is it supplied?
500 mL flexible PVC containers
What can be used instead?
Other Canadian products sharing ATC code B05AA55 DEXTRAN,COMBINATIONS. 2 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LMD 10% IN 0.9% SODIUM CHLORIDE | 0.9 % | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00224227 |
| 10% DEXTRAN 40 IN 0.9% SODIUM CHLORIDE INJECTION | 0.9 % | SOLUTION | B. BRAUN MEDICAL INC | CANCELLED POST MARKET | DIN 01924206 |
| 10% DEXTRAN 40 IN 5% DEXTROSE INJECTION | 5 % | SOLUTION | B. BRAUN MEDICAL INC | CANCELLED POST MARKET | DIN 01924249 |
| 6% DEXTRAN 70 IN 0.9% SODIUM CHLORIDE INJECTION | 6 % | SOLUTION | B. BRAUN MEDICAL INC | CANCELLED POST MARKET | DIN 01924192 |
| DEXTRAN 6% IN 0.9% SODIUM CHLORIDE INJECTION | 9 MG | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00225436 |
| DEXTRAN 6% IN 5% DEXTROSE INJECTION | 50 MG | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00224219 |
| GENTRAN 40 10% DEXTROSE 5% INJ | 10 G / 100 ML | LIQUID | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 00454915 |
| GENTRAN 40 10% SODIUM CHLORIDE 0.9% INJ | 10 G / 100 ML | LIQUID | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 00454923 |
| GENTRAN-70 6% & SODIUM CHLORIDE 0.9% INJ | .9 % | SOLUTION | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 01981722 |
| MACRODEX 6% IN DEXTROSE | 6 G / 100 ML | LIQUID | PHARMACIA (CANADA) INC. | CANCELLED POST MARKET | DIN 00158542 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.